Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Preferred Shares Issued (2017 - 2024)

Historic Preferred Shares Issued for Northwest Biotherapeutics (NWBO) over the last 10 years, with Q3 2024 value amounting to $267000.0.

  • Northwest Biotherapeutics' Preferred Shares Issued fell 9480.85% to $267000.0 in Q3 2024 from the same period last year, while for Dec 2024 it was $8.2 million, marking a year-over-year decrease of 3847.71%. This contributed to the annual value of $8.2 million for FY2024, which is 3847.71% down from last year.
  • As of Q3 2024, Northwest Biotherapeutics' Preferred Shares Issued stood at $267000.0, which was down 9480.85% from $4.3 million recorded in Q2 2024.
  • In the past 5 years, Northwest Biotherapeutics' Preferred Shares Issued ranged from a high of $7.8 million in Q4 2022 and a low of $267000.0 during Q3 2024
  • In the last 3 years, Northwest Biotherapeutics' Preferred Shares Issued had a median value of $3.5 million in 2023 and averaged $3.7 million.
  • Data for Northwest Biotherapeutics' Preferred Shares Issued shows a peak YoY increase of 8177.98% (in 2024) and a maximum YoY decrease of 9480.85% (in 2024) over the last 5 years.
  • Northwest Biotherapeutics' Preferred Shares Issued (Quarter) stood at $7.8 million in 2022, then tumbled by 55.81% to $3.4 million in 2023, then crashed by 92.22% to $267000.0 in 2024.
  • Its Preferred Shares Issued stands at $267000.0 for Q3 2024, versus $4.3 million for Q2 2024 and $3.6 million for Q1 2024.